Difference between revisions of "Team:San Andres/Software"
| Line 20: | Line 20: | ||
<body> | <body> | ||
| + | <title>wiki</title> | ||
| + | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
| + | <meta name="generator" content="Google Web Designer 1.3.2.0521"> | ||
| + | <style type="text/css"> | ||
| + | html, body { | ||
| + | width: 100%; | ||
| + | height: 100%; | ||
| + | margin: 0px; | ||
| + | } | ||
| + | body { | ||
| + | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
| + | -webkit-transform-style: preserve-3d; | ||
| + | background-color: transparent; | ||
| + | } | ||
| + | </style> | ||
<title>wiki</title> | <title>wiki</title> | ||
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
| Line 60: | Line 75: | ||
padding: 0px 2.5em; | padding: 0px 2.5em; | ||
text-decoration: none; | text-decoration: none; | ||
| − | |||
-webkit-transition: 0.3s; | -webkit-transition: 0.3s; | ||
| + | transition: 0.3s; | ||
} | } | ||
nav a:hover { | nav a:hover { | ||
| Line 83: | Line 98: | ||
nav li li { | nav li li { | ||
max-height: 0px; | max-height: 0px; | ||
| − | |||
-webkit-transition: all 0.1s; | -webkit-transition: all 0.1s; | ||
| + | transition: all 0.1s; | ||
overflow: hidden; | overflow: hidden; | ||
width: 200px; | width: 200px; | ||
| Line 147: | Line 162: | ||
padding: 0px 2.5em; | padding: 0px 2.5em; | ||
text-decoration: none; | text-decoration: none; | ||
| − | |||
transition: 0.3s; | transition: 0.3s; | ||
| + | -webkit-transition: 0.3s; | ||
} | } | ||
nav a:hover { | nav a:hover { | ||
| Line 170: | Line 185: | ||
nav li li { | nav li li { | ||
max-height: 0px; | max-height: 0px; | ||
| − | |||
transition: all 0.1s; | transition: all 0.1s; | ||
| + | -webkit-transition: all 0.1s; | ||
overflow: hidden; | overflow: hidden; | ||
width: 200px; | width: 200px; | ||
| Line 344: | Line 359: | ||
.gwd-img-z62c { | .gwd-img-z62c { | ||
position: absolute; | position: absolute; | ||
| − | left: | + | left: 81.976891072528px; |
| − | top: | + | top: 655.778797348194px; |
| + | } | ||
| + | .gwd-p-twn1 { | ||
| + | text-align: justify; | ||
| + | } | ||
| + | .gwd-span-3ctj { | ||
| + | font-family: sans-serif; | ||
| + | font-size: 12.7px; | ||
| + | line-height: 19.05px; | ||
| + | background-color: rgb(255, 255, 255); | ||
| + | } | ||
| + | .gwd-p-8ky1 { | ||
| + | text-align: justify; | ||
} | } | ||
</style> | </style> | ||
| Line 381: | Line 408: | ||
<div> | <div> | ||
<div class="gwd-div-245r"> | <div class="gwd-div-245r"> | ||
| − | <p class=" | + | <p class="gwd-p-twn1">The celiac disease affects 1 in 265 people worldwide and 15% of population in Chile. This in an irreversible autoimmune disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those affected, the consumption of foods containing gluten |
| − | worldwide and 15% of population in Chile. This in an irreversible autoimmune | + | (all fods derived from wheat, barley, rye, etc.) cause an inflammation in small intestine causing multiple effects in the organism (diarrhea, constipation, porr absorption, among others) significantly affecting their quatily of life.<small><span class="gwd-span-3ctj"> </span></small> |
| − | disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those | + | |
| − | affected, the consumption of foods containing gluten (all | + | |
| − | wheat, barley, rye, etc) cause an inflammation in small intestine causing | + | |
| − | multiple effects in the organism (diarrhea, constipation, | + | |
| − | among others) significantly affecting their | + | |
| − | + | ||
| − | + | ||
| − | + | ||
</p> | </p> | ||
| − | < | + | <p class="gwd-p-8ky1">Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the |
| − | world food contains gluten, we propose a treatment for those who can't eat | + | operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People |
| − | gluten, and can do so without problems. In detail, our project involves a | + | who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.</p> |
| − | system able to degrade gluten via the enzyme KumaMax and report the | + | |
| − | simultaneously with a red fluorescent protein. The foregoing, works in a | + | |
| − | genetically modified E.coli bacteria. With this project, in long run, we hope | + | |
| − | to improve the quality of life of all those reported with celiac disease. | + | |
| − | People who suffer from gluten intolerance have an adverse reaction to gluten | + | |
| − | proteins found in wheat, barley and rye products.</ | + | |
| − | + | ||
</div><span lang="EN-US" class="gwd-span-03v9"> | </div><span lang="EN-US" class="gwd-span-03v9"> | ||
<!--[if !supportLineBreakNewLine]--><br> | <!--[if !supportLineBreakNewLine]--><br> | ||
Revision as of 00:30, 13 August 2015
Abstract
The celiac disease affects 1 in 265 people worldwide and 15% of population in Chile. This in an irreversible autoimmune disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those affected, the consumption of foods containing gluten (all fods derived from wheat, barley, rye, etc.) cause an inflammation in small intestine causing multiple effects in the organism (diarrhea, constipation, porr absorption, among others) significantly affecting their quatily of life.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
